TGF-beta in neural stem cells and in tumors of the central nervous system

被引:0
|
作者
Ludwig Aigner
Ulrich Bogdahn
机构
[1] University of Regensburg,Department of Neurology
来源
Cell and Tissue Research | 2008年 / 331卷
关键词
Neurogenesis; Smad signaling; Cancer; Stem cells; Immune system; Brain;
D O I
暂无
中图分类号
学科分类号
摘要
Mechanisms that regulate neural stem cell activity in the adult brain are tightly coordinated. They provide new neurons and glia in regions associated with high cellular and functional plasticity, after injury, or during neurodegeneration. Because of the proliferative and plastic potential of neural stem cells, they are currently thought to escape their physiological control mechanisms and transform to cancer stem cells. Signals provided by proteins of the transforming growth factor (TGF)-beta family might represent a system by which neural stem cells are controlled under physiological conditions but released from this control after transformation to cancer stem cells. TGF-beta is a multifunctional cytokine involved in various physiological and patho-physiological processes of the brain. It is induced in the adult brain after injury or hypoxia and during neurodegeneration when it modulates and dampens inflammatory responses. After injury, although TGF-beta is neuroprotective, it may limit the self-repair of the brain by inhibiting neural stem cell proliferation. Similar to its effect on neural stem cells, TGF-beta reveals anti-proliferative control on most cell types; however, paradoxically, many brain tumors escape from TGF-beta control. Moreover, brain tumors develop mechanisms that change the anti-proliferative influence of TGF-beta into oncogenic cues, mainly by orchestrating a multitude of TGF-beta-mediated effects upon matrix, migration and invasion, angiogenesis, and, most importantly, immune escape mechanisms. Thus, TGF-beta is involved in tumor progression. This review focuses on TGF-beta and its role in the regulation and control of neural and of brain-cancer stem cells.
引用
收藏
页码:225 / 241
页数:16
相关论文
共 50 条
  • [31] Neural stem cells in the adult nervous system
    Bottai, D
    Fiocco, R
    Gelain, F
    Defilippis, L
    Galli, R
    Gritti, A
    Vescovi, LA
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2003, 12 (06): : 655 - 670
  • [32] EXPRESSION OF THE TGF-BETA FAMILY AND THE TGF-BETA RECEPTOR IN THE HUMAN THYMIC EPITHELIAL-CELLS (TEC)
    SCHLUNS, KS
    GRUTKOSKI, PS
    ENGELMANN, GL
    LE, PT
    FASEB JOURNAL, 1994, 8 (04): : A479 - A479
  • [33] Identification and isolation of human neural stem/progenitor cells of central nervous system.
    Uchida, N
    Buck, D
    He, D
    Reitsma, M
    Masek, M
    Phan, T
    Tsukamoto, A
    Gage, F
    Weissman, I
    BLOOD CELLS MOLECULES AND DISEASES, 2000, 26 (05) : 506 - 506
  • [34] Neural Stem Cells in Neurospheres, Embryoid Bodies, and Central Nervous System of Human Embryos
    Sathananthan, A. Henry
    MICROSCOPY AND MICROANALYSIS, 2011, 17 (04) : 520 - 527
  • [35] Neural stem/progenitor cells as promising candidates for regenerative therapy of the central nervous system
    Bonnamain, Virginie
    Neveu, Isabelle
    Naveilhan, Philippe
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2012, 6
  • [36] Protective roles of melatonin in central nervous system diseases by regulation of neural stem cells
    Yu, Xin
    Li, Zheng
    Zheng, Heyi
    Ho, Jeffery
    Chan, Matthew T. V.
    Wu, William Ka Kei
    CELL PROLIFERATION, 2017, 50 (02)
  • [37] The effect of TGF-beta on glioma initiating cells
    Seoane, J.
    EJC SUPPLEMENTS, 2010, 8 (05): : 160 - 160
  • [38] Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo
    Larsson, J
    Blank, U
    Klintman, J
    Magnusson, M
    Karlsson, S
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (07) : 89 - 89
  • [39] TGF-beta control of receptor expression in quiescent human hematopoietic stem/progenitor cells
    Hatzfeld, J
    Batard, P
    Panterne, B
    Fortunel, N
    Ducos, K
    Sansilvestri, P
    Monier, MN
    Hatzfeld, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 790 - 790
  • [40] Tetracycline regulatable transgenic mouse model for TGF-beta signalling: Inhibition of TGF-beta pathway in hematopoietic cells by dominant negative TGF-beta receptor II.
    Mikkola, H
    Valdimarsdottir, G
    Andersson, E
    Larsson, J
    Jacobsen, SE
    ten Dijke, P
    Karlsson, S
    BLOOD, 1999, 94 (10) : 686A - 686A